Supreme Court Blocks Policy Targeting Gender-Affirming Care in Federal Prisons
The Supreme Court has blocked a Trump administration policy that aimed to suspend hormone therapy and other gender-affirming treatments for transgender individuals in federal prisons, marking a rare setback for the administration and a victory for transgender rights advocates.
Monterey Salinas, CA, October 21, 2026 —
The Supreme Court blocked a Trump administration policy that aimed to suspend hormone therapy and other gender-affirming treatments for transgender people in federal prisons. The decision is described as a rare setback for the administration and a victory for transgender rights advocates.
The available information does not specify when the court acted, how the justices voted, or what legal reasoning supported the decision. It also does not identify the case, describe the policy’s exact terms, or say whether the court’s action is temporary or final.
The policy’s stated target was the provision of hormone therapy and other gender-affirming treatments to transgender individuals in federal prisons. The summary does not provide details about how many people could have been affected, how treatment had been handled before the policy, or what changes may follow the court’s action.
The ruling’s precise scope and practical effect are not provided. The available account also does not include statements from the administration, affected individuals, or advocates. It characterizes the outcome as a win for transgender rights advocates, but offers no further explanation of their response.
Without those details, the immediate consequences for treatment in federal prisons remain unclear. The information provided establishes that the Supreme Court blocked the policy, but does not indicate whether the administration may take further steps or whether additional proceedings are expected.
Story summarized from the original created by CNN Newsource on kioncentralcoast.com, see more information here.
Media gallery
